This site is intended for healthcare professionals

scPharmaceuticals Inc. has resubmitted its NDA to the FDA for Furoscix for the treatment of congestion in patients with heart failure.

Read time: 1 mins
Last updated:2nd Jul 2020
Published:2nd Jul 2020
Condition: Heart Failure
Type: drug
Register free for full access to